Bionomics Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bionomics Limited with three other
companies in this sector in Australia:
sales of 3.89 million Australian Dollars [US$2.80 million]
of which 62%
Oncosil Medical Ltd
(4.59 million Australian Dollars [US$3.30 million]
Benitec Biopharma Limited
(4.62 million Australian Dollars [US$3.32 million]
Sales fell dramatically in 2018:
During the year ended June of 2018, sales at
Bionomics Limited were A$3.95 million (US$2.84 million).
decrease of 78.7%
versus 2017, when the company's sales were A$18.61 million.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Bionomics Limited had sales
of A$3.72 million.
Contributing to the drop in overall sales was the 92.7% decline
in Drug Discovery and Development, from A$16.42 million to A$1.20 million.
However, these declines were partially offset by the increase in sales of
Contract Services (up 23.2% to A$7.09 million)
Corporate (up 27.6% to A$200,532.00 )